Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer

Journal:

Cancer Research

Published:

2025-08-01

DOI:

10.1158/0008-5472.can-24-3478

Affiliations:

14

Authors:

23

Go to article

Institutions	Authors	Share
University of Michigan (U-M), United States of America (USA)	13.416667 13.416667	0.58
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	2.333333	0.10
The Chinese University of Hong Kong (CUHK), China	2.000000	0.09
University of Notre Dame (ND), United States of America (USA)	2.000000	0.09
University of Michigan Rogel Cancer Center, United States of America (USA)	1.750000	0.08
Harvard Medical School (HMS), United States of America (USA)	1.000000	0.04
Ain Shams University, Egypt	0.500000	0.02

Interested in Oncology and Carcinogenesis?